Although there is nothing really new here, pre-eminent health economist Victor Fuchs has once again described the US Health system dilemma with eloquence in the NEJM’s Health Policy and Reform section. Fuchs describes the dilemma between providing the best care possible for each patient, whilst maintaining the cost-effective management of limited clinical resources. It is … Continue reading What is “appropriate” care?
From the freely-accessible abstract linked above: “Since the serendipitous discovery that drugs used to treat narcolepsy (modafinil) and attention deficit hyperactivity disorder (such as methylphenidate and atomoxetine) can improve the brainpower of healthy people, public and scientific interest has grown. Although the current level of use among doctors is unknown, data indicate that a large … Continue reading A pro-use stance on performance-enhancing drugs for doctors